Article
SHP2 mutations induce precocious gliogenesis of Noonan syndrome-derived iPSCs during neural development in vitro.
Stem cell research & therapy - 3 Jun 2020
Ju Younghee, Park Jun Sung, Kim Daejeong, Kim Bumsoo, Lee Jeong Ho, Nam Yoonkey, Yoo Han-Wook, Lee Beom Hee, Han Yong-Mahn
Abstract excerpt
BACKGROUND: Noonan syndrome (NS) is a developmental disorder caused by mutations of Src homology 2 domain-containing protein tyrosine phosphatase 2 (SHP2). Although NS patients have diverse neurological manifestations, the mechanisms underlying the involvement of SHP2 mutations in neurological dysfunction remain elusive. METHODS: Induced pluripotent stem cells generated from dermal fibroblasts of three...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
